Pages that link to "Q44188994"

The following pages link to Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep (Q44188994):

Displaying 38 items.

• Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1 (Q24308848) (← links)
• Urocortin induces positive inotropic effect in rat heart (Q28577408) (← links)
• A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease (Q28588519) (← links)
• Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs (Q30487401) (← links)
• cAMP‐ and Ca2+/calmodulin‐dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes (Q34143216) (← links)
• Corticotropin-releasing factor signaling and visceral response to stress (Q35203621) (← links)
• Peripheral corticotropin-releasing factor receptor type 2 activation increases colonic blood flow through nitric oxide pathway in rats (Q35564811) (← links)
• Distribution of urocortins and corticotropin-releasing factor receptors in the cardiovascular system (Q35996841) (← links)
• Comparative pharmacokinetics and pharmacodynamics of urocortins 1, 2 and 3 in healthy sheep (Q36110601) (← links)
• Urocortin Treatment Improves Acute Hemodynamic Instability and Reduces Myocardial Damage in Post-Cardiac Arrest Myocardial Dysfunction. (Q36188738) (← links)
• The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure (Q37074843) (← links)
• Intravenous adeno-associated virus serotype 8 encoding urocortin-2 provides sustained augmentation of left ventricular function in mice (Q37159046) (← links)
• Bench-to-bedside review: the value of cardiac biomarkers in the intensive care patient. (Q37192660) (← links)
• Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure. (Q37261607) (← links)
• Urocortin: a protective peptide that targets both the myocardium and vasculature (Q37421191) (← links)
• NFAT transcription factor regulation by urocortin II in cardiac myocytes and heart failure (Q37629215) (← links)
• Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents (Q37858515) (← links)
• Relevance of urocortins to cardiovascular disease. (Q37892087) (← links)
• Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests (Q37970489) (← links)
• The corticotropin releasing factor system in the kidney: perspectives for novel therapeutic intervention in nephrology (Q38012654) (← links)
• Targeting urocortin signaling pathways to enhance cardioprotection: is it time to move from bench to bedside? (Q38119156) (← links)
• Clinical perspectives of urocortin and related agents for the treatment of cardiovascular disease (Q42038020) (← links)
• New targets of urocortin-mediated cardioprotection (Q42709174) (← links)
• Effect of long-term treatment with urocortin on the activity of somatic angiotensin-converting enzyme in spontaneously hypertensive rats (Q43125776) (← links)
• Muscarinic effects and foetal cardiovascular and hormonal responses in utero (Q43755622) (← links)
• Cardiac expression of urocortin (Ucn) in diseased heart; preliminary results on possible involvement of Ucn in pathophysiology of cardiac diseases (Q44631137) (← links)
• The increase of blood flow in the fetal middle cerebral artery correlates with the onset of labor at term (Q46684133) (← links)
• Endothelial urocortin has potent antioxidative properties and is upregulated by inflammatory cytokines and pitavastatin (Q46844592) (← links)
• Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure (Q48155771) (← links)
• The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure. (Q48232718) (← links)
• Increased interleukin-6 receptor expression in the paraventricular nucleus of rats with heart failure (Q48374527) (← links)
• Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes. (Q54689954) (← links)
• A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage. (Q55019304) (← links)
• Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension-induced left ventricular hypertrophy and heart failure. (Q55052811) (← links)
• Myotrophin in human heart failure (Q73837030) (← links)
• Effects of intravenous urocortin on angiotensin-converting enzyme in rats (Q82604898) (← links)
• Urocortin 3 Inhibits Cardiac Sympathetic Nerve Activity in Conscious Sheep (Q84423654) (← links)
• Urocortins in the mammalian endocrine system (Q90488283) (← links)